Abstract
Regulable enzymes displaying foreign peptides are valuable instruments for molecular targeting and fast analyte detection in homogeneous assays. Both the specificity and the intensity of the signal generated by the sensor are critical parameters that can be manipulated by trial-and-error protein engineering in the vicinity of the active site. An alternative approach is presented to enhance signal-background ratio in β-galactosidase-based molecular sensors by an optimisation of the sensing conditions. The screening of the enzymatic response in a set of engineered enzymes has revealed an antibody-dependent increase in their specific activity up to 500% for the enzyme, HD72CA, that is reached with 0.25 pmol enzyme per reaction in presence of 1.75 mM substrate. This value, much higher than 200% enzyme activation achieved only by protein engineering, represents a step further in enhancing the enzyme's responsiveness. On the other hand, engineered β-galactosidases are also highly dynamic without preliminary antibody incubation, rendering activation factors around 300% after global reaction times shorter than 15 min. Therefore, this enzymatic system has been revealed as extremely robust and suitable for efficient and fast molecular detection in the diagnosis of infectious diseases.
Similar content being viewed by others
References
Benito A, Feliu JX, Villaverde A (1996) Beta-galactosidase enzymatic activity as a molecular probe to detect specific antibodies. J. Biol. Chem. 271: 21251-21256.
Benito A, Mateu MG, Villaverde A (1995) Improved mimicry of a foot-and-mouth diseae virus antigenic site by a viral peptide displayed on α-galactosidase surface. BioTechnology 13: 801-804.
Benito A, Vidal M, Villaverde A (1993) Enhanced production of PL-controlled recombinant proteins and higher plasmid copy number in Escherichia coli RecA+ strains. J. Biotechnol. 29: 299-306.
Brennan C, Christianson K, Surowy T, Mandecki W (1994) Modulation of enzyme activity by antibody binding to an alkaline phosphatase-epitope hybrid protein. Protein Eng. 7: 509-514.
Brennan CA, Christianson K, La Fleur MA, Mandecki W (1995) A molecular sensor system based on genetically engineered alkaline phosphatase. Proc. Natl. Acad. Sci. USA 92: 5783-5787.
Cazorla D, Feliu JX, Villaverde A (2001) Variable specific activity of Escherichia coli β-galactosidase in bacterial cells. Biotechnol. Bioeng. 72: 255-260.
Doi N, Yanagawa H (1999a) Design of generic biosensors based on green fluorescent proteins with allosteric sites by directed evolution. FEBS Lett. 453: 305-307.
Doi N, Yanagawa H (1999b) Insertional gene fusion technology. FEBS Lett. 457: 1-4.
Feliu JX, Villaverde A (1998) Engineering of solvent-exposed loops in Escherichia coli β-galactosidase. FEBS Lett. 434: 23-27.
Feliu JX, Ramírez E, Villaverde A (1998a) Distinct mechanisms of antibody-mediated enzymatic reactivation in α-galactosidase molecular sensors. FEBS Lett. 438: 267-271.
Feliu JX, Cubarsí R, Villaverde A (1998b) Optimized release of recombinant proteins by ultrasonication of E. coli cells. Biotechnol. Bioeng. 58: 536-540.
Feliu JX, Benito A, Oliva B, Avilés X, Villaverde A (1998c) Conformational flexibility in a highly mobile protein loop of foot-and-mouth disease virus: distinct structural requirements for integrin and antibody binding. J. Mol. Biol. 283: 331-338.
Feliu JX, Ramírez E, Villaverde A (2000a) Corrigendum to: distinct mechanisms of antibody-mediated enzymatic reactivation in α-galactosidase molecular sensors. FEBS Lett. 473: 123.
Feliu JX, Carbonell C, Villaverde A (2000b) Successful mimicry of a complex viral antigen by multiple peptide insertions in a carrier protein. FEBS Lett. 474: 87-92.
Ferrer-Miralles N, Feliu JX, Vandevuer S, Müller A, Cabrera-Crespo J, Ortmans I, Hoffmann F, Cazorla D, Rinas U, Prévost M, Villaverde A (2001) Engineering regulable E. coli β-galactosidases as biosensors for anti-HIV antibody detection in human sera. J. Biol. Chem. 276: 40087-40095.
Ferrer-Miralles N, Feliu JX, Villaverde A (2000) Molecular mechanisms for antibody-mediated modulation of peptide-displaying enzyme sensors. Biophys. Biochem. Res. Commun. 275: 360-364.
Legendre D, Soumillion P, Fastrez J (1999) Engineering a regulatable enzyme for homogeneous immunoassays. Nat. Biotechnol. 17: 67-72.
Mateu MG, Martínez MA, Capucci L, Andreu D, Giralt E, Sobrino F, Brocchi E, Domingo E (1990) A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. J. Gen. Virol. 71: 629-637.
Miller JH (1972) in Experiments in Molecular Genetics. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory.
Ramírez E, Más JM, Carbonell X, Avilés X, Villaverde A (1999) Detection of molecular interactions by using a new peptidedisplaying bacteriophage biosensor. Biophys. Biochem. Res. Commun 262: 801-805.
Sambrook J, Fritsch EF, Maniatis T (1985) in Molecular Cloning, A Laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory.
Schauder B, Blöcker H, Frank R, McCarthy JEG (1987) Inducible expression vectors incorporating the Escherichia coli atpE translational initiation region. Gene 52: 279-283.
Sobrino F, Dávila M, Ortín J, Domingo E (1983) Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology 128: 310-318.
Studier FW, Moffat BA (1986) Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J. Mol. Biol. 189: 113-130.
Ullman A (1984) One-step purification of hybrid proteins which have α-galactosidase activity. Gene 29: 27-31.
Verdaguer N, Schoehn G, Ochoa WF, Fita I, Brookes S, King A, Domingo E, Mateu MG, Stuart D, Hewat EA (1999) Flexibility of the major antigenic loop of foot-and-mouth disease virus bound to a Fab fragment of a neutralising antibody: structure and neutralisation. Virology 255: 260-268.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cazorla, D., Feliu, J.X., Ferrer-Miralles, N. et al. Tailoring molecular sensing for peptide displaying engineered enzymes. Biotechnology Letters 24, 469–477 (2002). https://doi.org/10.1023/A:1014590324002
Issue Date:
DOI: https://doi.org/10.1023/A:1014590324002